You're looking at Less Wrong's discussion board. This includes all posts, including those that haven't been promoted to the front page yet. For more information, see About Less Wrong.

Douglas_Knight comments on Whole genome sequencing vs SNP genotyping - Less Wrong Discussion

5 Post author: harcisis 11 June 2015 10:09PM

You are viewing a comment permalink. View the original post to see all comments and the full post content.

Comments (9)

You are viewing a single comment's thread. Show more comments above.

Comment author: Lumifer 12 June 2015 03:34:45PM *  4 points [-]

If the baseline is a 30% chance of dying of heart disease and it told you that you had a 70% chance, what would you do differently? (but it won't.) Probably you should already be doing it because 30% is a big number!

That line of argument is flawed because actions have costs.

To give a simple example (and discussing whether it's precisely correct is besides the point), you can take baby aspirin to reduce the risk of heart attacks. Aspirin is a blood thinner, it makes clots (which cause heart attacks) less likely. However decreasing coagulation is not an unmitigated blessing. If you get internal bleeding -- e.g. a blood vessel ruptured in your brain -- that aspirin you've been taking could make things significantly worse. It's a trade-off.

Given this, you want to know on which side (basically, heart attacks vs. strokes) is your personal risk the highest. It is actionable knowledge.

an 80% chance of breast cancer, which is really not that different from a 20% chance

Looks very different to me -- you are quite cavalier with a fourfold difference in odds...

Comment author: Douglas_Knight 12 June 2015 04:46:51PM 1 point [-]

4 is a small number. It is pretty rare that a cost-benefit calculation cares about that factor of 4, that multiplying the benefits by 4 will change the decision from reject to accept.

Comment author: Lumifer 12 June 2015 04:49:53PM 4 points [-]

It seems we have a different perception of smallness and tend to encounter different cost-benefit calculations.